Ultrasound Sees Increased Use for Interventional Procedures

摘要

With last year's U.S. Food and Drug Administration (FDA) approval of transcatheter aortic valve replacement (TAVR) and increasingly complex cath lab and hybrid operating room (OR) interventions, ultrasound is playing an increasing role in procedural guidance.This is especially true for use of 3-D/4-D transesophageal echo (TEE), which enables the more precise surgical-view visualization required for structural heart procedures, such as atrial septal defect (ASD) occluder and MitraClip deployments.These repairs would otherwise be extremely difficult to accomplish using fluoroscopy alone.